420 with CNW – Legislator Wants Sharing of Missouri Medical Cannabis Patient Info with Feds Banned

This year’s midterm elections saw the passing of a ballot initiate to legalize medical cannabis in Missouri. Now a legislator has pre-filed a bill which will prevent any state official or agency from sharing information about medical cannabis patients in the state with any federal authority.

The bill, sponsored by Republican Nick Schroer intends to make it a Class E felony for any state official to share with the federal government any information about the people holding medical cannabis cards in the state. Anyone convicted for this offense risks a custodial sentence of up to four years.

While it is rare for the Justice Department to prosecute individuals who use medical cannabis in states where it is legal, such a step isn’t entirely unheard of. The protracted case of three family members in Washington is a stark reminder that anything can happen as long as marijuana is still regarded as a strictly controlled illegal substance by the federal government.

Currently, a spending rider passed by Congress stops the federal government from using tax dollars to prosecute individuals who use medical cannabis in states where legalization has taken place.

Why, you may be wondering, would Nick Shroer deem it necessary to propose a bill on a matter that seems to have been settled by Congress? The reason is that policies can shift at the federal level at any time.

State law is therefore necessary to insulate patients from any policy changes that can put them in the crosshairs of the federal government.

Such laws are also intended to send a strong message that the states have their own right to pass and implement their own laws without having to bow to the wishes of the federal government.

Current events show that federal prosecutors are having meetings in different states where cannabis has been legalized in some form during the recent midterms in order to discuss how those policy changes will impact the work of federal prosecutors. This is a good sign that shows that the feds are adjusting to the changes taking place at the state level even if those changes contrast with the position held at the federal level.

Earth Science Tech, Inc. (OTCQB: ETST) and FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) welcome the legal protections that the legislator from Missouri wants to see for medical cannabis patients. Such protections ensure that people in dire need of relief from their medical conditions aren’t looked at as criminals who should be locked up.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Interactive Cannabis Museum Opens in Las Vegas

The marijuana industry looks poised to grow massively, and the current wave of legalization in different US states has paved the way for entrepreneurs and innovators to bring new products to the market. The latest addition to the cannabis world is an interactive cannabis museum in downtown Las Vegas aptly named “Cannibition”.

This museum is the brainchild of J.J Walker. He felt that marijuana needed to be given an immersive experience akin to what ice cream, pizza, avocadoes and other products get.

The entrepreneur intends to teach visitors to Cannibition about the entire journey of cannabis from when it is a seed until it is consumed. With a ticket going for $24, museum visitors can expect an unforgettable treat that will see them observe a cannabis grow operation, admire the largest cannabis bong in the world, literally take a dive into a huge pool of cannabis buds, and have so many other cannabis-related experiences.

J.J Walker isn’t just getting into the cannabis industry. He was in thick of things when Colorado legalized medical marijuana in 2008 and he opened a dispensary at a time when the state didn’t have any regulations in place for the industry.

Walker sold the dispensary about three years later and started a cannabis tour company. He operated that tour company for four years and his work there led him to be inspired to start the museum.

He felt that people interested in cannabis deserved better. For example, the cannabis lounges in states where adult-use cannabis is legal aren’t anything to post on Instagram because they tend to be plain locations with seats where people can smoke their joints and leave half an hour later.

Cannibition is intended to address that shortcoming and give cannabis consumers and non-consumers an experience they will enjoy while learning about the plant.

For example, the experienced of “being smoked” into giant red lips before emerging on the other side to the different fragrances of cannabis will thrill all your senses. The experience of touching the 24-foot largest bong in the world is also exhilarating. Everything was designed to be “Instagrammable”, so your smartphone camera will have a very busy time while you are in the museum.

Walker selected Las Vegas because of the 43 million visitors that come there each year. He sees an opportunity to teach as many people as possible about cannabis so that the transformation of cannabis from the shunned “weed” to a lifestyle can be completed sooner.

Remember that the world’s largest cannabis superstore was also opened in Las Vegas, so the city seems to be carving a place for itself as the cannabis capital of the world. Cannabis industry participants like Earth Science Tech, Inc. (OTCQB: ETST) and FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) congratulate J.J Walker and his team for contributing to the cannabis culture.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Iowa Doctors Reluctant to Embrace Medical Marijuana Program

Iowa is set to launch its new medical marijuana program on December 1 but the doctors within the state seem lukewarm towards this development. Currently, only 325 out of the 7,000 doctors in the state have certified patients to start receiving medical marijuana.

Under Iowa state law, doctors cannot prescribe medical marijuana since it is a controlled substance. They can only give patients written confirmation of the condition for which the patients are eligible to enroll on the medical marijuana program.

The patient can then buy medical cannabis from authorized dispensaries after receiving a medical cannabis card from the state. So far, approximately 600 patients have been certified to get on the medical cannabis program.

Many doctors, such as oncologist Richard Deming, say that they are uneasy about participating in the program because they haven’t seen any scientific research to prove that cannabis has medicinal value.

He also adds that it is hard to recommend a treatment when there isn’t any information regarding the dosing levels for the substance that someone will take as medicine. Deming added that the whole program is different from the way doctors were trained to administer medicine or provide health care.

The Des Maine oncologist ends by saying that it would be helpful if the federal government eased the restrictions on marijuana research so that more scientific data can become available on the medicinal uses of cannabis.

The views of Dr. Deming were echoed by another doctor, Steven Adelman. The physician has only certified a single patient so far. He says more cannabis research is needed to address the concerns of the medical professionals.

Dr. Adelman says that in the present circumstances, one would conclude that the hype about the medical uses of cannabis has gone ahead of any scientific basis for those claims. This needs to be corrected, he adds.

The operators of the licensed medical cannabis dispensaries feel frustrated by the reluctance of doctors to take the first step needed to get patients on the medical marijuana program. They feel that a great disservice is being done to patients since some are reporting that they are finding it difficult to discuss medical cannabis with their primary healthcare givers.

It is unfortunate that such issues are coming up when the state has just expanded the list of qualifying conditions from only uncontrollable seizure disorders and intractable epilepsy to the current list that has nearly two dozen qualifying conditions.

However, there is hope that more doctors will come on board as more awareness drives are conducted to allay any fears they may have. FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF), Generation Alpha, Inc. (OTCQB: GNAL) and other industry players would love to see the concerns of the doctors addressed quickly so that patients can get the care they need.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Canadian Employers Meet to Discuss Cannabis Legalization Implications

The cannabis forum of the Retail Council of Canada (RCC) met last month to discuss the workplace implications of cannabis legalization. The forum speakers and participants raised some issues that all employers need to think about as they adjust to the new reality in the country.

The first issue related to the medical cover provided to employees. Employers were asked to think about how they would respond if employees filed claims for medical cannabis benefits. Does the law compel the employer to provide such cover, or it is left to employers to decide whether to provide those benefits?

The second concern had to do with preventing impaired employees from showing up at work. Questions were raised about how the right of the employees to consume recreational cannabis could be married to the need to prevent impairment at work.

There was a suggestion that employers can impose consumption guidelines similar to what other sensitive sectors, such as the airline industry, impose on employees. For example, pilots are instructed to refrain from taking alcohol within a certain number of hours before they are scheduled to fly a plane.

The employers were cautioned to avoid imposing a blanket ban on cannabis consumption since that would be illegal and expose them to liability issues. Only those employers who could prove that the job required total abstinence could take such action. For example, it would be reasonable to restrict security guards from consuming recreational cannabis on the job or some hours before their shift begins.

There was a call for scientific data on how long someone can be impaired after consuming cannabis. Such data would provide a basis upon which employers can draft cannabis policies for their employees.

The issue of impaired customers was also raised. It is one thing to provide guidelines for your employees and it is a totally different matter when it comes to impaired customers in retail outlets.

Members in attendance suggested that employees need to be given some training regarding how to handle customers who visit retail establishments while apparently impaired after consuming cannabis.

The possible fear of being stigmatized for consuming recreational marijuana also came up. A speaker at the forum predicted that some employees may falsely claim that they are medical cannabis users in order to explain away their impairment while at work.

Other members suggested that it would be reasonable for employers to ask employees for a copy of their documentation for medical cannabis to prevent such false claims. However, the employer should not ask for the diagnosis upon which the authorization card was issued since that would be overstepping the acceptable boundaries.

The forum ended with members agreeing that more sessions need to be organized so that people can continue to share experiences and ideas regarding the workplace implications of cannabis legalization. Such healthy and progressive discussions are music to the ears of cannabis companies like Earth Science Tech, Inc. (OTCQB: ETST) and FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) since such discussions differ from the polarized, adversarial pronouncements that are made in some jurisdictions.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Using Your Credit Card to Buy Pot in Canada Could Affect Your US Admissibility

Canadians who are queuing to buy recreational marijuana may be unwittingly making it harder to be allowed to travel to the U.S. if the federal government in America doesn’t soften its hard stance on the marijuana industry.

This concern takes on greater importance given that federal agents at entry points have the leeway to perform any background check necessary before admitting someone into the country. Those background checks can include looking into how someone has been using his or her credit cards.

People who have bought cannabis using their credit cards therefore face the risk of being denied entry into the U.S. since the authorities there may view them as individuals who are connected to an illegal industry (even if marijuana is legal in Canada for both medical and recreational use).

The possibility of having your credit card history reviewed may increase in case the CBP (Customs and Border Protection) agents ask a traveler about cannabis and they have reason to suspect that the person isn’t being truthful in his or her responses.

Canadians shouldn’t imagine that the sheer numbers of people traveling across the border to the South is so high that it may be practically impossible for the border agents to look at everyone’s credit card history. It is possible, and you may be that one person who is singled out for such a background check.

The Canadian province of Ontario currently only allows residents to use their MasterCard or Visa cards to buy recreational cannabis online. This means that the people in this province are at a higher risk of being in the crosshairs of the American border agents if credit card purchases are ever looked into before one is allowed to cross into the U.S.

Don’t rely on the words of comfort coming from the different tech giants like Google, Amazon and Microsoft saying that they will protect the data of Canadians. The Patriot Act can be invoked to compel those companies to release any information that the US government requires in its bid to keep the homeland secure.

Over time, the position of the US is likely to evolve in order to accommodate its neighbor since keeping all Canadians involved in the cannabis industry as workers, investors or consumers out of the country may end up hurting the US. Until that time comes, one should use his or her credit card for making marijuana purchases only when it is unavoidable. Even Americans who cross into Canada and buy cannabis using their credit cards may be affected later on even if the border agents cannot stop them from returning home.

The fears resulting from differences in the laws governing marijuana in different jurisdictions also give cannabis companies like ChineseInvestors.com (OTCQB: CIIX) and FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) major headaches that they would wish to see end sooner rather than later.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Lithuania Joins List of EU Nations Where Medical Cannabis is Legal

The parliament of Lithuania has passed a law that will make it possible for patients who want to be treated with marijuana to get such treatment. This new law will become operational on May 1, 2019. An overwhelming majority (nearly unanimous) of legislators voted in for this law. No legislator voted against the proposal while one lawmaker abstained.

Any company intending to sell medical cannabis once the new law takes effect will need to get a license from the relevant regulator in the country.

The passing of the law which legalized medical cannabis necessitated that some existing laws, such as the law on Narcotics and Psychotropic Substances, be amended to take into account the legalization of medical marijuana.

One of the provisions of the narcotics law regarded marijuana as having no medicinal use. Such a provision would have been inconsistent with the new law which regarded cannabis as a form of medicine.

The law legalizing medical cannabis has some strict requirements for any cannabis product that manufacturers want to use to treat patients. For example, scientific research will have to be conducted to prove that a given product has a medicinal effect upon the condition for which such a product can be used.

The medicines control agency of the country will be responsible for issuing permits for any clinical trials that need to be conducted.

Aurora Cannabis, one of the leading marijuana companies in Canada, already has a presence in the country. This was after the Canadian company acquired Agropro UAB in September this year.

Agropro had for long occupied the position of the largest firm involved in the production, processing and supply of organic hemp products in Europe.

Registered cannabis products will be used to treat oncological patients in Lithuania. Qualifying conditions will include HIV/AIDS, multiple sclerosis, severe epilepsy and other chronic conditions.

Other EU jurisdictions which have recently legalized medical cannabis include the UK which passed the relevant law and implementation is scheduled to start just weeks after that law was passed. This is contrary to what happens in other jurisdictions where several months or even years have to elapse before implementation starts. The delays are usually necessitated by the need to set up regulatory systems and process applications for businesses that want to be involved in the industry.

Lithuania is taking it slow and giving itself more than half a year before patients can access medical marijuana. Cannabis companies around the world, such as Earth Science Tech, Inc. (OTCQB: ETST) and FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) are certainly happy that more jurisdictions around the world are opening up to the medical benefits that cannabis can offer those in need.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Alaska Decides to Modify Marijuana Taxes

The state of Alaska has decided to make some changes to the way it taxes marijuana. These changes were prompted by concerns raised by industry players regarding the lack of distinction between different kinds of cannabis buds.

The type of bud plays a role in the quality (and the price) of any products that are derived from that bud. The tax authorities haven’t been putting this into consideration, an oversight that made legal cannabis very pricey hence inadvertently promoting the black market.

Currently, each ounce of cannabis flower or bud is taxed $50 while trim (the rest of the plant) incurs a $15 tax per ounce. These taxes are paid by the grower as the produce is sent to a manufacturing facility or to a retail store where it is sold as dry bud or any other unprocessed form of the plant.

The new tax measures which will start being implemented on January 1, 2019 will see mature flower or bud incur an excise tax of $50 an ounce while the abnormal or immature flower will attract a $25 tax for each ounce. The rest of the plant will still be taxed at the same level as before, which is, $15 an ounce.

The planned tax changes will see three tiers of taxes for different kinds of marijuana. Many industry participants see these changes as insufficient and they are calling for wide ranging modifications.

However, those broader changes can only be made by the legislative arm of the state by modifying the law under which cannabis became legal in Alaska.

Conducting such extensive reforms would be a time-consuming process that would involve numerous steps, such as conducting hearings in order to gather views from the public and other stakeholders before the appropriate committee prepares a report to be voted on by all legislators.

Alaskans voted in 2014 to decriminalize recreational marijuana and that ballot measure took effect towards the end of February the following year.

Supply shortages compelled many marijuana retailers to close shop for a while in December 2016 and the first month of 2017. These businesses reopened once the shortages were fixed.

The existing tax policy was threatening to take some marijuana companies out of business and the limited changes being made are attempts to allow businesses to lock in some profits so that the industry can remain robust. Earth Science Tech, Inc. (OTCQB: ETST) and FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) can only hope that all jurisdictions move to make the business environment more favorable to the players.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Connecticut Federal Court Rules in Favor of Employees Taking Medical Marijuana

A federal district court has ruled that a nursing home violated the anti-discriminatory act when it rescinded a job offer to a job seeker who declared that she consumes medical cannabis off-duty and tested positive for THC in a pre-employment drugs test. Medical cannabis is legal in Connecticut where the plaintiff lives and sought to be employed by the nursing home.

The case was filed by the plaintiff last year and judgment was delivered last month, more than a year later. The defendant had tried to get the case dismissed arguing that federal laws allowed them to deny users of a controlled substance employment.

However, the federal district court ruled that the defendant couldn’t cite the Controlled Substances Act since the laws of Connecticut granted protections to patients who had a qualifying condition and were consuming marijuana in accordance with the state laws.

The plaintiff’s request for legal fees and punitive damages was denied by the federal court since the Connecticut law (Palliative Use of Medical Marijuana or PUMA) under which she sued did not prescribe such remedies in its protections for patients on medical cannabis.

The ruling against Bride Brook Nursing and Rehabilitation Center comes at a time when courts had initially ruled against employees on matters of medical marijuana. It is the first time that a federal court is making a decision in favor of an employee.

Other state courts had made similar favorable rulings for employees against employers who took action against them for consuming medical marijuana.

The decision by the federal court isn’t binding on all the other courts, but one can be certain that this case will be a point of reference in any future litigation on similar matters.

In fact, Bride Brook Nursing and Rehabilitation Center can appeal against this decision in order to have it reversed.

The case law on medical marijuana is still scanty since so few states have decriminalized it while it remains illegal at the federal law.

It may therefore be premature for anyone to think that the legal tide is shifting in favor of employees. All the same, it is wise for employers to review their policies regarding marijuana testing as a precondition for employment since they may expose themselves to costly suits that may leave the reputation of the companies in question in tatters.

What can help all concerned is some form of middle ground to be reached between the states where marijuana is legal and the federal level where decriminalization hasn’t occurred as yet. This is certainly the wish of industry players like Earth Science Tech, Inc. (OTCQB: ETST) and FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) who want to see a more uniform regulatory framework.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

420 with CNW – FBI Data Shows Increased Marijuana Arrests in 2017

New data that has just been released by the U.S. Federal Bureau of Investigations (FBI) reveals that the marijuana arrests made in 2017 were more than those which were recorded in 2016. These statistics are surprising given the fact that, by the end of 2017, 28 states had legalized medical or recreational consumption of cannabis.

In total, 659,700 people were arrested on marijuana-related charges in 2017, while the figure for 2016 stood at 653,349 arrests.

The wave of cannabis legalization doesn’t seem to have had any impact upon the law enforcement community, especially at the federal level. This is creating a measure of confusion in the public, since daily dilemmas arise regarding the subject of cannabis.

An example of the confusion is the position of Los Angeles International Airport permitting travelers to carry marijuana while the federal transportation authorities at the same airport retain the right to detain anyone found in possession of cannabis.

The FBI data reflects the same mixed signals. For example, about 91 percent of all those arrests were for simple possession of cannabis. That is a high figure given that 20 percent of the American population lives in a state where some form of cannabis legalization exists.

To put this in context, someone was arrested somewhere in the U.S. for marijuana related issues every 48 seconds throughout 2017.

Activists are livid at these statistics, given that about 100 people die each day in the country due to opioid overdoses yet no death has been reported anywhere as a result of a cannabis overdose. Cannabis advocates wondered why the efforts and the meager resources of law enforcement agencies couldn’t be directed where the real danger lies.

To put this misallocation of resources differently, the FBI data shows that for each person who was arrested for murder there were 49 individuals arrested on a marijuana-related charge.

This overzealousness on the part of law enforcement flies counter to the growth in public opinion favoring the use of cannabis either for recreational or medical purposes. If the trend of arrests continues, voters may be compelled to pile pressure on their elected leaders to rein in the law enforcement arm of government, which seems oblivious to what is happening in the states where cannabis is legal. Global Payout, Inc. (OTC: GOHE) and FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) must be wishing that the unclear regulatory climate around cannabis settles quickly so that the industry can shape up for the good of all concerned.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

420 with CNW – UCLA Team to Investigate the Painkilling Effects of Cannabis

The U.S. Centers for Disease Control and Prevention (CDC) reported that 42,000 Americans died from an overdose of opioids in 2016 alone. Meanwhile, the consumption of cannabis by members of the American public has been growing rapidly over the years. How are these two issues related to the planned research on cannabis?

Plenty of anecdotal evidence exists to support the claim that cannabis has painkilling abilities. Several scientific studies also point to the possibility of cannabis having painkilling effects. However, little reliable scientific information is available to support or disprove those claims.

That may no longer be the case if the proposed study by a team of researchers from the University of California Los Angeles (UCLA) is completed successfully.

The researchers would like to ascertain what combination of CBD and THC provides the highest degree of painkilling effects for opioid patients.

Dr. Jeffrey Chen is the Executive Director of the Cannabis Research Initiative, which came up with the idea of conducting this study.

The actual study was designed by a professor of psychiatry and pharmacology, Edythe London. She explained that the research isn’t intended to provide evidence for or against the cannabis industry. The study is a scientific undertaking to understand a substance that is reputed to have so many medicinal effects.

The double-blind, placebo-controlled clinical study seeks to shed some light on one particular claim, the claim that cannabis can help to ease the pain suffered by patients.

The success of the study in proving that cannabis can combat pain would provide a glimmer of hope that a solution may be at hand for the opioid crisis facing the nation. Such a solution is desperately wanted, given the fact that about 40 percent of the opioid overdose fatalities reported by the CDC in 2016 were connected to prescription opioids.

Dr. Chen points out that the scientific community needs to play catch up quickly so that more information can be available to the public about cannabis. This information could save people from falling for yet-to-be-substantiated claims by cannabis product manufacturers.

However, the researchers have a huge task to overcome two major obstacles before the study can commence.

First, cannabis is federally regarded as a schedule 1 controlled substance, “a substance without any medical value and has a high potential for addictiveness.” The researchers must convince the Food and Drug Administration (FDA), as well as the Drug Enforcement Agency (DEA), to grant them permission to proceed with the study. It isn’t clear how easy, or how quickly, such regulatory approval can be secured.

Secondly, the researchers must look for funding for their study. Some money has been secured from UCLA’s Semel Institute for Neuroscience and Human Behavior and from some private donors. Additional funding requests have been made to local and federal sources. Entities like Canopy Rivers Corporation (TSX: WEED) (NYSE: CGC) and FinCanna Capital Corp. (CSE: CALI) (OTC: FNNZF) must be keeping their fingers crossed, hoping that the necessary funding and approval is obtained so that the debate on the painkilling effects of marijuana can be put to rest once and for all.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net